13F Data
13F filer · CIK 1750183

Antara Capital LP

New York, NY · filing since Q4 2018 · last filing Feb 17, 2026
Reported value
$30.2K
$-460.0K vs prior
Positions
2
New / sold out
0 / 1
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $442.2K
Top-10 weight
100.0%

Biggest buys vs Q3 2025

No new or increased positions this quarter.

Biggest sells vs Q3 2025

ChangeSecurityShares changeChange %Est. trade value
Sold outCURRENC GROUP INC-263,200-100.0%$-442.2K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2018: $146.2MQ1 2019: $354.5MQ2 2019: $459.0MQ3 2019: $215.7MQ4 2019: $493.5MQ1 2020: $616.9MQ2 2020: $898.8MQ3 2020: $718.8MQ4 2020: $482.0MQ1 2021: $1.2BQ2 2021: $1.8BQ3 2021: $1.3BQ4 2021: $2.0BQ1 2022: $3.3BQ2 2022: $2.4BQ3 2022: $3.8BQ4 2022: $3.6BQ1 2023: $2.5BQ2 2023: $3.0BQ3 2023: $1.1BQ4 2023: $1.5BQ1 2024: $170.0MQ2 2024: $149.8MQ3 2024: $58.7MQ4 2024: $63.8MQ1 2025: $119.1KQ2 2025: $1.1MQ3 2025: $490.2KQ4 2025: $30.2K
Q4 2018Q4 2025

Holdings · Q4 2025

#SecuritySharesValueWeight
1ASPIRE BIOPHARMA HLDGS INCCOM202,897$26.8K88.65%
2ASPIRE BIOPHARMA HLDGS INC*W EXP 02/14/203207,693$3.4K11.35%